查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1810921

2025年全球吸入性皮质类固醇设备市场报告

Inhaler Corticosteroid Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

吸入式皮质类固醇设备市场预计将在未来几年强劲成长，到2029年将达到217.7亿美元，复合年增长率为6.6%。预测期内的成长动力包括呼吸系统疾病的增加、呼吸健康意识的增强、对呼吸技术的大量投资、对健康教育的重视程度的提高以及吸烟成瘾的增加。预计影响这一时期的关键趋势包括智慧技术的采用、联合治疗的开发、能够即时监控的数位吸入器的引入、吸入器设计的进步以及数据分析在吸入器设备中的应用。

预计呼吸系统疾病盛行率的上升将在未来几年推动吸入性皮质类固醇装置市场的成长。呼吸系统疾病包括影响肺部和呼吸道的多种疾病，会损害正常和有效的呼吸。呼吸系统疾病的增加归因于空气污染的加剧，人们暴露在有害颗粒中，这些颗粒会损害肺组织并引发气喘和支气管炎等慢性疾病。吸入性皮质类固醇装置透过将抗发炎药物直接输送到肺部来治疗呼吸系统疾病，有助于减轻发炎并改善呼吸。例如，2025 年 6 月，英国健康改善和消除不平等署报告称，2024 财年，英格兰因呼吸系统疾病紧急住院的人数为 854,922 人，相当于每 100,000 人口中有 1,428 人（范围为 1,424 至 1,432 人），比上一年增长 7%。因此，呼吸系统疾病的日益流行正在刺激吸入性皮质类固醇装置市场的扩张。

吸入性皮质类固醇装置市场的主要企业正致力于推出创新解决方案，例如沙丁胺醇和Budesonide复方急救吸入器，以提高治疗效果并透过单一装置为患者提供更便捷的双重作用疗法。沙丁胺醇和Budesonide复方急救吸入器使用支气管扩张剂（沙丁胺醇）快速打开气道，并使用皮质类固醇（Budesonide）减轻炎症，从而通过单一装置快速缓解症状并长期控制气喘。例如，2024 年 1 月，英国製药公司阿斯特捷利康公司推出了 AIRSUPRA，这是第一个也是唯一一个获得 FDA核准的用于成年气喘患者的沙丁胺醇和Budesonide复方急救吸入器。这种吸入药物旨在按需使用，以缓解急性支气管收缩症状并减少气道炎症，从而降低严重气喘发作的风险。这种新方法将短效β-2促效剂（沙丁胺醇）和吸入性皮质类固醇（Budesonide）结合在一个吸入器中，并根据临床试验核准，证明了其在预防气喘发作方面优于单独使用沙丁胺醇。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球吸入性皮质类固醇设备：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球吸入性皮质类固醇设备市场：成长率分析
  • 全球吸入性皮质类固醇设备市场表现：规模与成长，2019-2024
  • 全球吸入性皮质类固醇设备市场预测：规模与成长，2024-2029 年，2034 年
  • 全球吸入性皮质类固醇设备：总目标市场（TAM）

第六章市场区隔

  • 全球吸入性皮质类固醇设备市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 定量吸入器
  • 干粉吸入器
  • 缓雾吸入器
  • 全球吸入性皮质类固醇设备市场（依处方类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • Fluticasone propionate
  • Budesonide
  • 倍氯米松
  • 糠酸Mometasone
  • 全球吸入性皮质类固醇设备市场：按分销管道、实际数据及预测，2019-2024 年、2024-2029 年、2034 年
  • 网路药局
  • 零售药局
  • 直销
  • 医院药房
  • 全球吸入性皮质类固醇设备市场：按应用、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 气喘
  • 慢性阻塞性肺病（COPD）
  • 其他用途
  • 全球吸入性皮质类固醇设备市场（依最终用户、实际及预测）2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 居家护理
  • 专科诊所
  • 其他最终用户
  • 全球吸入性皮质类固醇设备市场：按定量喷雾吸入器细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 传统定量吸入器
  • 呼吸驱动定量吸入器
  • 带有集成垫片的定量吸入器
  • 全球吸入性皮质类固醇设备市场：干粉吸入器细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 单剂量干粉吸入器
  • 多剂量干粉吸入器
  • 储药式干粉吸入器
  • 全球吸入性皮质类固醇设备市场：缓雾吸入器细分市场（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 手动缓雾吸入器
  • 电池供电的缓雾吸入器

第七章 区域和国家分析

  • 全球吸入性皮质类固醇设备市场：区域分析、预测及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球吸入性皮质类固醇设备市场：国家/地区、实际资料及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 吸入性皮质类固醇设备市场：竞争格局
  • 吸入性皮质类固醇设备市场：公司简介
    • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Teijin Pharma Limited
  • Sun Pharmaceutical Industries Limited
  • Aurobindo Pharma Limited
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • Hikma Pharmaceuticals PLC
  • Amneal Pharmaceuticals Inc.
  • Mundipharma International Limited
  • Lupin Limited
  • Zydus Lifesciences Limited
  • Recipharm AB
  • Glenmark Pharmaceuticals Limited
  • Orion Corporation
  • Beximco Pharmaceuticals Limited
  • PARI Medical Holding GmbH

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年吸入性皮质类固醇设备市场：提供新机会的国家
  • 2029年吸入性皮质类固醇设备市场：细分市场带来新机会
  • 吸入性皮质类固醇设备市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r37023

An inhaler corticosteroid device is a specialized medical instrument designed to deliver anti-inflammatory corticosteroid medication directly into the lungs. This targeted delivery reduces swelling and irritation in the airways caused by chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). By acting locally in the lungs, these devices help control and prevent symptoms like wheezing, shortness of breath, and coughing, while limiting the systemic side effects often associated with oral corticosteroids.

The primary types of inhaler corticosteroid devices include metered-dose inhalers, dry powder inhalers, and soft mist inhalers. Metered-dose inhalers (MDIs) are portable devices that release a precise, measured dose of medication into the lungs as an aerosol. These inhalers use various drug formulations such as fluticasone propionate, budesonide, beclomethasone, and mometasone furoate. They are distributed through online and retail pharmacies, direct sales, and hospital pharmacies. These devices are widely used for managing conditions like asthma and COPD, with end users including hospitals, home care providers, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The inhaler corticosteroid device market research report is one of a series of new reports from The Business Research Company that provides inhaler corticosteroid device market statistics, including inhaler corticosteroid device industry global market size, regional shares, competitors with an inhaler corticosteroid device market share, detailed inhaler corticosteroid device market segments, market trends and opportunities, and any further data you may need to thrive in the inhaler corticosteroid device industry. This inhaler corticosteroid device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inhaler corticosteroid device market size has grown strongly in recent years. It will grow from $15.75 billion in 2024 to $16.83 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period was driven by rising healthcare spending, a growing elderly population, favorable government policies, ongoing research and development efforts, and higher disposable incomes.

The inhaler corticosteroid device market size is expected to see strong growth in the next few years. It will grow to $21.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during the forecast period is driven by an increase in respiratory disorders, heightened awareness of respiratory health, substantial investments in respiratory technologies, an expanding focus on health education, and a rise in smoking addiction. Key trends expected to influence this period include the adoption of smart technologies, development of combination therapies, introduction of digital inhalers with real-time monitoring, advancements in inhaler design, and the use of data analytics in inhaler devices.

The rising prevalence of respiratory diseases is expected to drive the growth of the inhaler corticosteroid device market in the coming years. Respiratory diseases encompass a variety of conditions affecting the lungs and airways, which impair proper and efficient breathing. The increase in respiratory diseases is attributed to growing air pollution, exposing people to harmful particles that damage lung tissue and trigger chronic conditions such as asthma and bronchitis. Inhaler corticosteroid devices treat respiratory diseases by delivering anti-inflammatory medication directly to the lungs, helping to reduce inflammation and improve breathing. For example, in June 2025, the UK's Office for Health Improvement and Disparities reported that in the financial year ending 2024, England recorded 854,922 emergency hospital admissions for respiratory diseases, corresponding to a rate of 1,428 (ranging from 1,424 to 1,432) per 100,000 population-a 7% increase compared to the previous year. Therefore, the growing prevalence of respiratory diseases is fueling the expansion of the inhaler corticosteroid device market.

Leading companies in the inhaler corticosteroid device market are focusing on launching innovative solutions, such as rescue inhalers that combine albuterol and budesonide to improve treatment efficacy and provide patients with a more convenient, dual-action therapy within a single device. An inhaler combining albuterol and budesonide is a dual-action rescue inhaler that delivers both a bronchodilator (albuterol) to rapidly open airways and a corticosteroid (budesonide) to reduce inflammation, offering quick symptom relief and long-term asthma control in one device. For instance, in January 2024, AstraZeneca PLC, a UK-based pharmaceutical company, introduced AIRSUPRA, the first and only FDA-approved rescue inhaler combining albuterol and budesonide for adults with asthma. This inhaler is intended for as-needed use to relieve acute bronchoconstriction symptoms and reduce airway inflammation, thereby lowering the risk of severe asthma attacks. It represents a novel approach by combining a short-acting beta2-agonist (albuterol) with an inhaled corticosteroid (budesonide) in a single inhaler, with approval based on clinical trials demonstrating its superiority over albuterol alone in preventing asthma exacerbations.

In March 2022, Sandoz Group AG, a Switzerland-based company specializing in generic pharmaceuticals and biosimilars, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition aims to strengthen Sandoz's position in developing and delivering complex, high-quality respiratory therapies by incorporating Coalesce's advanced expertise in innovative drug delivery device design and manufacturing. This supports Sandoz's broader strategy to expand its value-added medicines portfolio and reinforce its commitment to patient-focused, integrated treatment solutions. Coalesce Product Development Limited is a UK-based medical device company specializing in designing and developing respiratory drug delivery devices, including inhalers for inhaled corticosteroids.

Major players in the inhaler corticosteroid device market are AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Teijin Pharma Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Mundipharma International Limited, Lupin Limited, Zydus Lifesciences Limited, Recipharm AB, Glenmark Pharmaceuticals Limited, Orion Corporation, Beximco Pharmaceuticals Limited, PARI Medical Holding GmbH, and Kos Pharmaceuticals Inc.

North America was the largest region in the inhaler corticosteroid device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inhaler corticosteroid device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the inhaler corticosteroid device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The inhaler corticosteroid device market consists of sales of nebulizer solutions, manual soft mist inhalers, conventional metered-dose inhalers, and combination inhalers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inhaler Corticosteroid Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhaler corticosteroid device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhaler corticosteroid device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The inhaler corticosteroid device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Metered-Dose Inhalers; Dry Powder Inhalers; Soft Mist Inhalers
  • 2) By Formulation Type: Fluticasone Propionate; Budesonide; Beclomethasone; Mometasone Furoate
  • 3) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Direct Sales; Hospital Pharmacies
  • 4) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Other Applications
  • 5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Metered-Dose Inhalers: Conventional Metered-Dose Inhalers; Breath-Actuated Metered-Dose Inhalers; Spacer-Integrated Metered-Dose Inhalers
  • 2) By Dry Powder Inhalers: Single-Dose Dry Powder Inhalers; Multi-Dose Dry Powder Inhalers; Reservoir Dry Powder Inhalers
  • 3) By Soft Mist Inhalers: Manual Soft Mist Inhalers; Battery-Operated Soft Mist Inhalers
  • Companies Mentioned: AstraZeneca PLC; Novartis AG; GlaxoSmithKline plc; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Ltd.; Teijin Pharma Limited; Sun Pharmaceutical Industries Limited; Aurobindo Pharma Limited; Chiesi Farmaceutici S.p.A.; Cipla Limited; Hikma Pharmaceuticals PLC; Amneal Pharmaceuticals Inc.; Mundipharma International Limited; Lupin Limited; Zydus Lifesciences Limited; Recipharm AB; Glenmark Pharmaceuticals Limited; Orion Corporation; Beximco Pharmaceuticals Limited; PARI Medical Holding GmbH; Kos Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Inhaler Corticosteroid Device Market Characteristics

3. Inhaler Corticosteroid Device Market Trends And Strategies

4. Inhaler Corticosteroid Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Inhaler Corticosteroid Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Inhaler Corticosteroid Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Inhaler Corticosteroid Device Market Growth Rate Analysis
  • 5.4. Global Inhaler Corticosteroid Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Inhaler Corticosteroid Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Inhaler Corticosteroid Device Total Addressable Market (TAM)

6. Inhaler Corticosteroid Device Market Segmentation

  • 6.1. Global Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered-Dose Inhalers
  • Dry Powder Inhalers
  • Soft Mist Inhalers
  • 6.2. Global Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluticasone Propionate
  • Budesonide
  • Beclomethasone
  • Mometasone Furoate
  • 6.3. Global Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online Pharmacies
  • Retail Pharmacies
  • Direct Sales
  • Hospital Pharmacies
  • 6.4. Global Inhaler Corticosteroid Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Other Applications
  • 6.5. Global Inhaler Corticosteroid Device Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users
  • 6.6. Global Inhaler Corticosteroid Device Market, Sub-Segmentation Of Metered-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional Metered-Dose Inhalers
  • Breath-Actuated Metered-Dose Inhalers
  • Spacer-Integrated Metered-Dose Inhalers
  • 6.7. Global Inhaler Corticosteroid Device Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Dry Powder Inhalers
  • Multi-Dose Dry Powder Inhalers
  • Reservoir Dry Powder Inhalers
  • 6.8. Global Inhaler Corticosteroid Device Market, Sub-Segmentation Of Soft Mist Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Soft Mist Inhalers
  • Battery-Operated Soft Mist Inhalers

7. Inhaler Corticosteroid Device Market Regional And Country Analysis

  • 7.1. Global Inhaler Corticosteroid Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Inhaler Corticosteroid Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inhaler Corticosteroid Device Market

  • 8.1. Asia-Pacific Inhaler Corticosteroid Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inhaler Corticosteroid Device Market

  • 9.1. China Inhaler Corticosteroid Device Market Overview
  • 9.2. China Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inhaler Corticosteroid Device Market

  • 10.1. India Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inhaler Corticosteroid Device Market

  • 11.1. Japan Inhaler Corticosteroid Device Market Overview
  • 11.2. Japan Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inhaler Corticosteroid Device Market

  • 12.1. Australia Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inhaler Corticosteroid Device Market

  • 13.1. Indonesia Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inhaler Corticosteroid Device Market

  • 14.1. South Korea Inhaler Corticosteroid Device Market Overview
  • 14.2. South Korea Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inhaler Corticosteroid Device Market

  • 15.1. Western Europe Inhaler Corticosteroid Device Market Overview
  • 15.2. Western Europe Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inhaler Corticosteroid Device Market

  • 16.1. UK Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inhaler Corticosteroid Device Market

  • 17.1. Germany Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inhaler Corticosteroid Device Market

  • 18.1. France Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inhaler Corticosteroid Device Market

  • 19.1. Italy Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inhaler Corticosteroid Device Market

  • 20.1. Spain Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inhaler Corticosteroid Device Market

  • 21.1. Eastern Europe Inhaler Corticosteroid Device Market Overview
  • 21.2. Eastern Europe Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inhaler Corticosteroid Device Market

  • 22.1. Russia Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inhaler Corticosteroid Device Market

  • 23.1. North America Inhaler Corticosteroid Device Market Overview
  • 23.2. North America Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inhaler Corticosteroid Device Market

  • 24.1. USA Inhaler Corticosteroid Device Market Overview
  • 24.2. USA Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inhaler Corticosteroid Device Market

  • 25.1. Canada Inhaler Corticosteroid Device Market Overview
  • 25.2. Canada Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inhaler Corticosteroid Device Market

  • 26.1. South America Inhaler Corticosteroid Device Market Overview
  • 26.2. South America Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inhaler Corticosteroid Device Market

  • 27.1. Brazil Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inhaler Corticosteroid Device Market

  • 28.1. Middle East Inhaler Corticosteroid Device Market Overview
  • 28.2. Middle East Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inhaler Corticosteroid Device Market

  • 29.1. Africa Inhaler Corticosteroid Device Market Overview
  • 29.2. Africa Inhaler Corticosteroid Device Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Inhaler Corticosteroid Device Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Inhaler Corticosteroid Device Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inhaler Corticosteroid Device Market Competitive Landscape And Company Profiles

  • 30.1. Inhaler Corticosteroid Device Market Competitive Landscape
  • 30.2. Inhaler Corticosteroid Device Market Company Profiles
    • 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Inhaler Corticosteroid Device Market Other Major And Innovative Companies

  • 31.1. Teijin Pharma Limited
  • 31.2. Sun Pharmaceutical Industries Limited
  • 31.3. Aurobindo Pharma Limited
  • 31.4. Chiesi Farmaceutici S.p.A.
  • 31.5. Cipla Limited
  • 31.6. Hikma Pharmaceuticals PLC
  • 31.7. Amneal Pharmaceuticals Inc.
  • 31.8. Mundipharma International Limited
  • 31.9. Lupin Limited
  • 31.10. Zydus Lifesciences Limited
  • 31.11. Recipharm AB
  • 31.12. Glenmark Pharmaceuticals Limited
  • 31.13. Orion Corporation
  • 31.14. Beximco Pharmaceuticals Limited
  • 31.15. PARI Medical Holding GmbH

32. Global Inhaler Corticosteroid Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inhaler Corticosteroid Device Market

34. Recent Developments In The Inhaler Corticosteroid Device Market

35. Inhaler Corticosteroid Device Market High Potential Countries, Segments and Strategies

  • 35.1 Inhaler Corticosteroid Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Inhaler Corticosteroid Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Inhaler Corticosteroid Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer